KIF5A and amyotrophic lateral sclerosis: Specifically, in HSP/Charcot-Marie-Tooth 2 patients, the majority of KIF5A mutations are situated in the motor domain, whereas ALS patients tend to have mutations in the C-terminal cargo-binding domain.